// App-Quantinova.ai

3834 : scFv antibodies against EphA2 receptor as a therapeutic strategy for AML

Researchers

Presenter

  • Michael Albert

Principal Investigators

  • Mayumi Sugita

  • Hongliang Zong

  • Juha Himanen

  • Monica L. Guzman

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved